South Korea has witnessed a rise in the prevalence of diabetes, both Type 1 and Type 2. The increasing number of individuals diagnosed with diabetes creates a growing demand for blood glucose monitoring devices to manage and monitor the condition effectively. The aging population in South Korea is more susceptible to diabetes. As the proportion of elderly individuals increases, so does the need for blood glucose monitoring devices to cater to this demographics healthcare needs. Increased awareness among the South Korean population about the importance of diabetes management and regular monitoring has led to greater demand for blood glucose monitoring devices. Education campaigns and public health initiatives contribute to this awareness. There is a growing trend toward patient empowerment and self-monitoring in healthcare. Blood glucose monitoring devices empower individuals with diabetes to actively participate in the management of their condition, leading to increased demand. According to NCBI, in 2021, 16.7% of Korean adults aged 30 or older had diabetes. This equates to about 6.05 million people. The prevalence of diabetes in South Korea increased from 10.3% in 2011 to 13.9% in 2020. Health insurance coverage in South Korea supports the affordability and accessibility of medical devices, including blood glucose monitoring devices. Insurance coverage encourages individuals to regularly monitor their glucose levels as part of their diabetes management. Patient advocacy organizations in South Korea play a crucial role in supporting individuals with diabetes. These organizations often provide resources, educational materials, and advocacy efforts that contribute to a better understanding of the importance of blood glucose monitoring. According to the research report “South Korea Blood Glucose Monitoring Devices Market Overview, 2028," published by Bonafide Research, the South Korea Blood Glucose Monitoring Devices market is anticipated to add more than USD 150 Million from 2023 to 2028. Continuous Glucose Monitoring (CGM) systems have gained popularity in South Korea. These systems offer real-time monitoring of glucose levels, providing more comprehensive data for better diabetes management. Blood glucose monitoring devices are increasingly integrated with digital health platforms and mobile applications. This integration allows users to track and manage their glucose levels digitally, facilitating better communication with healthcare providers. The adoption of telehealth services and remote patient monitoring has increased in South Korea, especially in response to the COVID-19 pandemic. Blood glucose monitoring devices that support remote monitoring align with the broader trend toward virtual healthcare consultations and services. Blood glucose monitoring functionalities are being integrated into wearable devices such as smartwatches and fitness trackers. This trend aligns with the broader adoption of wearable technologies for health and fitness monitoring. The integration of artificial intelligence (AI) in blood glucose monitoring devices is increasing. AI algorithms can analyze glucose data patterns, offer predictive insights, and assist both users and healthcare professionals in making more informed decisions. Manufacturers are recognizing the unique needs of pediatric populations with diabetes. Blood glucose monitoring devices with child-friendly designs and features that cater to the needs of children are gaining attention. Blood glucose monitoring devices are increasingly designed to connect seamlessly with smartphones. This connectivity allows for easier data sharing, remote monitoring, and the integration of glucose data into digital health applications.
Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally
Download SampleThe market is split into two categories based on product type: continuous blood glucose monitoring devices and self-monitoring devices. Self-monitoring devices contribute to patient empowerment by allowing individuals to take an active role in managing their health. These devices provide real-time data, enabling users to make informed decisions about their diet, medication, and lifestyle. Continuous advancements in technology have led to the development of sophisticated and user-friendly self-monitoring devices. Modern devices are often compact, require smaller blood samples, and may offer features like Bluetooth connectivity for seamless data sharing with healthcare providers. Self-monitoring devices provide a convenient and accessible way for individuals to monitor their blood glucose levels without the need for frequent visits to healthcare facilities. This is particularly important for individuals who prefer the comfort of managing their condition at home. The emphasis on preventive healthcare and early detection of health issues has increased the importance of self-monitoring devices. Regular monitoring allows for the timely identification of fluctuations in blood glucose levels, facilitating early interventions and preventive measures. Self-monitoring devices can be cost-effective in the long run, as they reduce the need for frequent laboratory tests or clinic visits. This cost efficiency may contribute to the widespread adoption of these devices by individuals managing diabetes. Considered in this report: • Geography: South Korea • Historic year: 2017 • Base year: 2022 • Estimated year: 2023 • Forecast year: 2028 Aspects covered in this report: • South Korea Blood Glucose Monitoring Devices market with its value and forecast along with its segments • Various drivers and challenges • On-going trends and developments • Top profiled companies • Strategic recommendation
By Product • Self-monitoring Devices • Continuous Blood Glucose Monitoring Devices By End User • Hospitals • Home Care • Diagnostic Centers By Indication • Diabetes • Pregnancy • Cardiovascular Disorders & Hypertension • Cancer • Respiratory Diseases • Movement Disorders • Hearing Disorders • Wound Care • Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)
The approach of the report: This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources. Intended audience: This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Blood Glucose Monitoring Devices industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.
We are friendly and approachable, give us a call.